Page last updated: 2024-08-23

flubendazole and Leukemia

flubendazole has been researched along with Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ashali, I; Beheshti Zavareh, R; Boss, J; Di Meo, A; Fine, N; Gronda, M; Hu, J; Hurren, R; Rottapel, R; Schimmer, AD; Sharmeen, S; Simpson, CD; Spagnuolo, PA; Sukhai, MA; Wang, X	1

Other Studies

1 other study(ies) available for flubendazole and Leukemia

Article	Year
The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma. Blood, 2010, Jun-10, Volume: 115, Issue:23 Topics: Animals; Antinematodal Agents; Antineoplastic Agents, Phytogenic; Cell Death; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; HeLa Cells; Humans; Leukemia; Male; Mebendazole; Mice; Microtubules; Multiple Myeloma; U937 Cells; Vinblastine; Vinca Alkaloids; Xenograft Model Antitumor Assays	2010

Article

Year

The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma.

Blood, 2010, Jun-10, Volume: 115, Issue:23

Topics: Animals; Antinematodal Agents; Antineoplastic Agents, Phytogenic; Cell Death; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; HeLa Cells; Humans; Leukemia; Male; Mebendazole; Mice; Microtubules; Multiple Myeloma; U937 Cells; Vinblastine; Vinca Alkaloids; Xenograft Model Antitumor Assays

2010